Podium to Practice: ASH® 2025 – LYMPHOMA: A real-world study from the DESCAR-T registry

Explore more from your favourite experts – click their name to access their entire library of content.

Studies / Trials Discussed

ID 1012 – CAR T-cell therapy in secondary CNS lymphomas: A real-world study from the descar-t registry

This program has been made possible through unrestricted support from Eli Lilly and Merck.

Studies/trials discussed:

ID 1012 – CAR T-cell therapy in secondary CNS lymphomas: A real-world study from the descar-t registry